ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diagnostic Nuclear Medicines Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-31Y9619
Home | Market Reports | Health| Pharmacy
Global Diagnostic Nuclear Medicines Market Insights Forecast to 2028
BUY CHAPTERS

Global Diagnostic Nuclear Medicines Market Research Report 2025

Code: QYRE-Auto-31Y9619
Report
September 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bracco Imaging
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
Siemens AG
Dongcheng
Cardinal Health
Curium Pharma
China Isotope & Radiation

Diagnostic Nuclear Medicines Market Size

The global market for Diagnostic Nuclear Medicines was valued at US$ 5363 million in the year 2024 and is projected to reach a revised size of US$ 8500 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Diagnostic Nuclear Medicines Market

Diagnostic Nuclear Medicines Market

Diagnostic radiopharmaceuticals. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
The diagnostic radioisotopes market is driven by the increasing prevalence of cancer and cardiovascular diseases, which require advanced imaging techniques for accurate diagnosis and treatment planning. Diagnostic radioisotopes are radioactive compounds used in nuclear medicine imaging to visualize and evaluate physiological processes and detect specific diseases in the body. The rise in the aging population and the need for early and precise diagnosis contribute to market growth. Moreover, advancements in radiopharmaceutical research and the development of new radioisotopes have improved the sensitivity and specificity of diagnostic imaging. However, the market also faces challenges, including the high cost of production and limited availability of some radioisotopes. Additionally, ensuring regulatory compliance and addressing concerns regarding radiation safety can pose obstacles for manufacturers and healthcare facilities. To succeed, companies must focus on research and development to offer innovative and diverse diagnostic radioisotopes, collaborate with healthcare providers to improve nuclear medicine imaging capabilities, and address the challenges to meet the increasing demand for effective and safe diagnostic imaging solutions.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Diagnostic Nuclear Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Nuclear Medicines.
The Diagnostic Nuclear Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Nuclear Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Nuclear Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Diagnostic Nuclear Medicines Market Report

Report Metric Details
Report Name Diagnostic Nuclear Medicines Market
Accounted market size in year US$ 5363 million
Forecasted market size in 2031 US$ 8500 million
CAGR 6.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Tc-99m
  • F-18
  • Other
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, Novartis, SIEMENS, China Isotope & Radiation, Dongcheng, Lantheus, Eli Lilly
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Diagnostic Nuclear Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Diagnostic Nuclear Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Diagnostic Nuclear Medicines Market growing?

Ans: The Diagnostic Nuclear Medicines Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Diagnostic Nuclear Medicines Market size in 2031?

Ans: The Diagnostic Nuclear Medicines Market size in 2031 will be US$ 8500 million.

Who are the main players in the Diagnostic Nuclear Medicines Market report?

Ans: The main players in the Diagnostic Nuclear Medicines Market are Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, Novartis, SIEMENS, China Isotope & Radiation, Dongcheng, Lantheus, Eli Lilly

What are the Application segmentation covered in the Diagnostic Nuclear Medicines Market report?

Ans: The Applications covered in the Diagnostic Nuclear Medicines Market report are Oncology, Cardiology, Other

What are the Type segmentation covered in the Diagnostic Nuclear Medicines Market report?

Ans: The Types covered in the Diagnostic Nuclear Medicines Market report are Tc-99m, F-18, Other

Recommended Reports

Nuclear Medicine

Radiopharmaceuticals

Radioisotopes & Diagnostics

1 Diagnostic Nuclear Medicines Market Overview
1.1 Product Definition
1.2 Diagnostic Nuclear Medicines by Type
1.2.1 Global Diagnostic Nuclear Medicines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tc-99m
1.2.3 F-18
1.2.4 Other
1.3 Diagnostic Nuclear Medicines by Application
1.3.1 Global Diagnostic Nuclear Medicines Market Value by Application (2024 VS 2031)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Nuclear Medicines Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Nuclear Medicines Revenue 2020-2031
1.4.2 Global Diagnostic Nuclear Medicines Sales 2020-2031
1.4.3 Global Diagnostic Nuclear Medicines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Diagnostic Nuclear Medicines Market Competition by Manufacturers
2.1 Global Diagnostic Nuclear Medicines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Diagnostic Nuclear Medicines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Diagnostic Nuclear Medicines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diagnostic Nuclear Medicines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diagnostic Nuclear Medicines, Product Type & Application
2.7 Global Key Manufacturers of Diagnostic Nuclear Medicines, Date of Enter into This Industry
2.8 Global Diagnostic Nuclear Medicines Market Competitive Situation and Trends
2.8.1 Global Diagnostic Nuclear Medicines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Diagnostic Nuclear Medicines Players Market Share by Revenue
2.8.3 Global Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Diagnostic Nuclear Medicines Market Scenario by Region
3.1 Global Diagnostic Nuclear Medicines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Diagnostic Nuclear Medicines Sales by Region: 2020-2031
3.2.1 Global Diagnostic Nuclear Medicines Sales by Region: 2020-2025
3.2.2 Global Diagnostic Nuclear Medicines Sales by Region: 2026-2031
3.3 Global Diagnostic Nuclear Medicines Revenue by Region: 2020-2031
3.3.1 Global Diagnostic Nuclear Medicines Revenue by Region: 2020-2025
3.3.2 Global Diagnostic Nuclear Medicines Revenue by Region: 2026-2031
3.4 North America Diagnostic Nuclear Medicines Market Facts & Figures by Country
3.4.1 North America Diagnostic Nuclear Medicines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Diagnostic Nuclear Medicines Sales by Country (2020-2031)
3.4.3 North America Diagnostic Nuclear Medicines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diagnostic Nuclear Medicines Market Facts & Figures by Country
3.5.1 Europe Diagnostic Nuclear Medicines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Diagnostic Nuclear Medicines Sales by Country (2020-2031)
3.5.3 Europe Diagnostic Nuclear Medicines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diagnostic Nuclear Medicines Market Facts & Figures by Region
3.6.1 Asia Pacific Diagnostic Nuclear Medicines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Diagnostic Nuclear Medicines Sales by Region (2020-2031)
3.6.3 Asia Pacific Diagnostic Nuclear Medicines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diagnostic Nuclear Medicines Market Facts & Figures by Country
3.7.1 Latin America Diagnostic Nuclear Medicines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Diagnostic Nuclear Medicines Sales by Country (2020-2031)
3.7.3 Latin America Diagnostic Nuclear Medicines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diagnostic Nuclear Medicines Market Facts & Figures by Country
3.8.1 Middle East and Africa Diagnostic Nuclear Medicines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Diagnostic Nuclear Medicines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Diagnostic Nuclear Medicines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Diagnostic Nuclear Medicines Sales by Type (2020-2031)
4.1.1 Global Diagnostic Nuclear Medicines Sales by Type (2020-2025)
4.1.2 Global Diagnostic Nuclear Medicines Sales by Type (2026-2031)
4.1.3 Global Diagnostic Nuclear Medicines Sales Market Share by Type (2020-2031)
4.2 Global Diagnostic Nuclear Medicines Revenue by Type (2020-2031)
4.2.1 Global Diagnostic Nuclear Medicines Revenue by Type (2020-2025)
4.2.2 Global Diagnostic Nuclear Medicines Revenue by Type (2026-2031)
4.2.3 Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2020-2031)
4.3 Global Diagnostic Nuclear Medicines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Diagnostic Nuclear Medicines Sales by Application (2020-2031)
5.1.1 Global Diagnostic Nuclear Medicines Sales by Application (2020-2025)
5.1.2 Global Diagnostic Nuclear Medicines Sales by Application (2026-2031)
5.1.3 Global Diagnostic Nuclear Medicines Sales Market Share by Application (2020-2031)
5.2 Global Diagnostic Nuclear Medicines Revenue by Application (2020-2031)
5.2.1 Global Diagnostic Nuclear Medicines Revenue by Application (2020-2025)
5.2.2 Global Diagnostic Nuclear Medicines Revenue by Application (2026-2031)
5.2.3 Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2020-2031)
5.3 Global Diagnostic Nuclear Medicines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Cardinal Health
6.1.1 Cardinal Health Company Information
6.1.2 Cardinal Health Description and Business Overview
6.1.3 Cardinal Health Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Cardinal Health Diagnostic Nuclear Medicines Product Portfolio
6.1.5 Cardinal Health Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Company Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GE Healthcare Diagnostic Nuclear Medicines Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Curium Pharma
6.3.1 Curium Pharma Company Information
6.3.2 Curium Pharma Description and Business Overview
6.3.3 Curium Pharma Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Curium Pharma Diagnostic Nuclear Medicines Product Portfolio
6.3.5 Curium Pharma Recent Developments/Updates
6.4 Jubilant Pharma
6.4.1 Jubilant Pharma Company Information
6.4.2 Jubilant Pharma Description and Business Overview
6.4.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Jubilant Pharma Diagnostic Nuclear Medicines Product Portfolio
6.4.5 Jubilant Pharma Recent Developments/Updates
6.5 Bracco Imaging
6.5.1 Bracco Imaging Company Information
6.5.2 Bracco Imaging Description and Business Overview
6.5.3 Bracco Imaging Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bracco Imaging Diagnostic Nuclear Medicines Product Portfolio
6.5.5 Bracco Imaging Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Diagnostic Nuclear Medicines Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 SIEMENS
6.7.1 SIEMENS Company Information
6.7.2 SIEMENS Description and Business Overview
6.7.3 SIEMENS Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 SIEMENS Diagnostic Nuclear Medicines Product Portfolio
6.7.5 SIEMENS Recent Developments/Updates
6.8 China Isotope & Radiation
6.8.1 China Isotope & Radiation Company Information
6.8.2 China Isotope & Radiation Description and Business Overview
6.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Product Portfolio
6.8.5 China Isotope & Radiation Recent Developments/Updates
6.9 Dongcheng
6.9.1 Dongcheng Company Information
6.9.2 Dongcheng Description and Business Overview
6.9.3 Dongcheng Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Dongcheng Diagnostic Nuclear Medicines Product Portfolio
6.9.5 Dongcheng Recent Developments/Updates
6.10 Lantheus
6.10.1 Lantheus Company Information
6.10.2 Lantheus Description and Business Overview
6.10.3 Lantheus Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Lantheus Diagnostic Nuclear Medicines Product Portfolio
6.10.5 Lantheus Recent Developments/Updates
6.11 Eli Lilly
6.11.1 Eli Lilly Company Information
6.11.2 Eli Lilly Description and Business Overview
6.11.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Eli Lilly Diagnostic Nuclear Medicines Product Portfolio
6.11.5 Eli Lilly Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diagnostic Nuclear Medicines Industry Chain Analysis
7.2 Diagnostic Nuclear Medicines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diagnostic Nuclear Medicines Production Mode & Process Analysis
7.4 Diagnostic Nuclear Medicines Sales and Marketing
7.4.1 Diagnostic Nuclear Medicines Sales Channels
7.4.2 Diagnostic Nuclear Medicines Distributors
7.5 Diagnostic Nuclear Medicines Customer Analysis
8 Diagnostic Nuclear Medicines Market Dynamics
8.1 Diagnostic Nuclear Medicines Industry Trends
8.2 Diagnostic Nuclear Medicines Market Drivers
8.3 Diagnostic Nuclear Medicines Market Challenges
8.4 Diagnostic Nuclear Medicines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bracco Imaging
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
Siemens AG
Dongcheng
Cardinal Health
Curium Pharma
China Isotope & Radiation
List of Tables
 Table 1. Global Diagnostic Nuclear Medicines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Diagnostic Nuclear Medicines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Diagnostic Nuclear Medicines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Diagnostic Nuclear Medicines Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Diagnostic Nuclear Medicines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Diagnostic Nuclear Medicines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Diagnostic Nuclear Medicines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Diagnostic Nuclear Medicines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Diagnostic Nuclear Medicines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Diagnostic Nuclear Medicines, Product Type & Application
 Table 12. Global Key Manufacturers of Diagnostic Nuclear Medicines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Diagnostic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Medicines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Diagnostic Nuclear Medicines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Diagnostic Nuclear Medicines Sales by Region (2020-2025) & (K Units)
 Table 18. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2020-2025)
 Table 19. Global Diagnostic Nuclear Medicines Sales by Region (2026-2031) & (K Units)
 Table 20. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2026-2031)
 Table 21. Global Diagnostic Nuclear Medicines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2020-2025)
 Table 23. Global Diagnostic Nuclear Medicines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2026-2031)
 Table 25. North America Diagnostic Nuclear Medicines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Diagnostic Nuclear Medicines Sales by Country (2020-2025) & (K Units)
 Table 27. North America Diagnostic Nuclear Medicines Sales by Country (2026-2031) & (K Units)
 Table 28. North America Diagnostic Nuclear Medicines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Diagnostic Nuclear Medicines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Diagnostic Nuclear Medicines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Diagnostic Nuclear Medicines Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Diagnostic Nuclear Medicines Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Diagnostic Nuclear Medicines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Diagnostic Nuclear Medicines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Diagnostic Nuclear Medicines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Diagnostic Nuclear Medicines Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Diagnostic Nuclear Medicines Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Diagnostic Nuclear Medicines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Diagnostic Nuclear Medicines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Diagnostic Nuclear Medicines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Diagnostic Nuclear Medicines Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Diagnostic Nuclear Medicines Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Diagnostic Nuclear Medicines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Diagnostic Nuclear Medicines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Diagnostic Nuclear Medicines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Diagnostic Nuclear Medicines Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Diagnostic Nuclear Medicines Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Diagnostic Nuclear Medicines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Diagnostic Nuclear Medicines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Diagnostic Nuclear Medicines Sales (K Units) by Type (2020-2025)
 Table 51. Global Diagnostic Nuclear Medicines Sales (K Units) by Type (2026-2031)
 Table 52. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2020-2025)
 Table 53. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2026-2031)
 Table 54. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2020-2025)
 Table 57. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2026-2031)
 Table 58. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Diagnostic Nuclear Medicines Sales (K Units) by Application (2020-2025)
 Table 61. Global Diagnostic Nuclear Medicines Sales (K Units) by Application (2026-2031)
 Table 62. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2020-2025)
 Table 63. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2026-2031)
 Table 64. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2020-2025)
 Table 67. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2026-2031)
 Table 68. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Application (2026-2031)
 Table 70. Cardinal Health Company Information
 Table 71. Cardinal Health Description and Business Overview
 Table 72. Cardinal Health Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Cardinal Health Diagnostic Nuclear Medicines Product
 Table 74. Cardinal Health Recent Developments/Updates
 Table 75. GE Healthcare Company Information
 Table 76. GE Healthcare Description and Business Overview
 Table 77. GE Healthcare Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. GE Healthcare Diagnostic Nuclear Medicines Product
 Table 79. GE Healthcare Recent Developments/Updates
 Table 80. Curium Pharma Company Information
 Table 81. Curium Pharma Description and Business Overview
 Table 82. Curium Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Curium Pharma Diagnostic Nuclear Medicines Product
 Table 84. Curium Pharma Recent Developments/Updates
 Table 85. Jubilant Pharma Company Information
 Table 86. Jubilant Pharma Description and Business Overview
 Table 87. Jubilant Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Jubilant Pharma Diagnostic Nuclear Medicines Product
 Table 89. Jubilant Pharma Recent Developments/Updates
 Table 90. Bracco Imaging Company Information
 Table 91. Bracco Imaging Description and Business Overview
 Table 92. Bracco Imaging Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Bracco Imaging Diagnostic Nuclear Medicines Product
 Table 94. Bracco Imaging Recent Developments/Updates
 Table 95. Novartis Company Information
 Table 96. Novartis Description and Business Overview
 Table 97. Novartis Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Novartis Diagnostic Nuclear Medicines Product
 Table 99. Novartis Recent Developments/Updates
 Table 100. SIEMENS Company Information
 Table 101. SIEMENS Description and Business Overview
 Table 102. SIEMENS Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. SIEMENS Diagnostic Nuclear Medicines Product
 Table 104. SIEMENS Recent Developments/Updates
 Table 105. China Isotope & Radiation Company Information
 Table 106. China Isotope & Radiation Description and Business Overview
 Table 107. China Isotope & Radiation Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. China Isotope & Radiation Diagnostic Nuclear Medicines Product
 Table 109. China Isotope & Radiation Recent Developments/Updates
 Table 110. Dongcheng Company Information
 Table 111. Dongcheng Description and Business Overview
 Table 112. Dongcheng Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Dongcheng Diagnostic Nuclear Medicines Product
 Table 114. Dongcheng Recent Developments/Updates
 Table 115. Lantheus Company Information
 Table 116. Lantheus Description and Business Overview
 Table 117. Lantheus Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Lantheus Diagnostic Nuclear Medicines Product
 Table 119. Lantheus Recent Developments/Updates
 Table 120. Eli Lilly Company Information
 Table 121. Eli Lilly Description and Business Overview
 Table 122. Eli Lilly Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Eli Lilly Diagnostic Nuclear Medicines Product
 Table 124. Eli Lilly Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Diagnostic Nuclear Medicines Distributors List
 Table 128. Diagnostic Nuclear Medicines Customers List
 Table 129. Diagnostic Nuclear Medicines Market Trends
 Table 130. Diagnostic Nuclear Medicines Market Drivers
 Table 131. Diagnostic Nuclear Medicines Market Challenges
 Table 132. Diagnostic Nuclear Medicines Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Diagnostic Nuclear Medicines
 Figure 2. Global Diagnostic Nuclear Medicines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Diagnostic Nuclear Medicines Market Share by Type: 2024 & 2031
 Figure 4. Tc-99m Product Picture
 Figure 5. F-18 Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Diagnostic Nuclear Medicines Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Diagnostic Nuclear Medicines Market Share by Application: 2024 & 2031
 Figure 9. Oncology
 Figure 10. Cardiology
 Figure 11. Other
 Figure 12. Global Diagnostic Nuclear Medicines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Diagnostic Nuclear Medicines Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Diagnostic Nuclear Medicines Sales (2020-2031) & (K Units)
 Figure 15. Global Diagnostic Nuclear Medicines Average Price (USD/Unit) & (2020-2031)
 Figure 16. Diagnostic Nuclear Medicines Report Years Considered
 Figure 17. Diagnostic Nuclear Medicines Sales Share by Manufacturers in 2024
 Figure 18. Global Diagnostic Nuclear Medicines Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Diagnostic Nuclear Medicines Players: Market Share by Revenue in Diagnostic Nuclear Medicines in 2024
 Figure 20. Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Diagnostic Nuclear Medicines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Diagnostic Nuclear Medicines Sales Market Share by Country (2020-2031)
 Figure 23. North America Diagnostic Nuclear Medicines Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Diagnostic Nuclear Medicines Sales Market Share by Country (2020-2031)
 Figure 27. Europe Diagnostic Nuclear Medicines Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Diagnostic Nuclear Medicines Revenue Market Share by Region (2020-2031)
 Figure 35. China Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Diagnostic Nuclear Medicines Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Diagnostic Nuclear Medicines Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Diagnostic Nuclear Medicines Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Diagnostic Nuclear Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Diagnostic Nuclear Medicines by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Diagnostic Nuclear Medicines by Type (2020-2031)
 Figure 57. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Diagnostic Nuclear Medicines by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Diagnostic Nuclear Medicines by Application (2020-2031)
 Figure 60. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Application (2020-2031)
 Figure 61. Diagnostic Nuclear Medicines Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Diagnostic Radioisotopes Market Insights Forecast to 2030
Diagnostic Nuclear Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Radiopharmaceuticals Market Research Report 2024
Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025
Global Radiopharmaceutical Therapy Market Research Report 2025
Global Radiopharmaceuticals for Diagnosis Market Research Report 2024
Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2024
Global SPECT and PET Radiopharmaceuticals Market Research Report 2024
Global Nuclear Medicine Market Research Report 2025
Global Radiopharmaceutical Market Research Report 2025
Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030
Global Therapeutic Radioisotopes Market Insights Forecast to 2030
Global Nuclear Medicine Radioisotopes Market Insights Forecast to 2030
Global Radioisotopes in Medicine Market Research Report 2025
Global Therapeutic Nuclear Medicines Market Insights Forecast to 2030
Global Medical Radioisotopes Market Research Report 2025
Global Radioactive Therapeutic Drugs Market Research Report 2024
Nuclear Medicine Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Radiopharmaceuticals Market Research Report 2024
Radiopharmaceuticals for Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions